ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company is headquartered in Ann Arbor, Michigan.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-5.72M |
| Operating Margin | 0.00% |
| Return on Equity | -291.60% |
| Return on Assets | -86.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.92 |
| Price-to-Book | 2.72 |
| Price-to-Sales (TTM) | 1838.78 |
| EV/Revenue | 1845.91 |
| EV/EBITDA | -0.11 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.24M |
| Float | $1.17M |
| % Insiders | 14.55% |
| % Institutions | 16.54% |
Volatility is currently contracting